Read + Share
. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as
first line chemotherapy in patients with recurrent or metastatic nasopharyngeal
carcinoma: randomised phase 3 clinical trial. BMJ 2024;385:q1381.
PMID: 38906541
|
 |
|
